TAYD vs UTHR · P/E 17, rev $41.6M vs P/E 20, rev $1.56B
Taylor Devices Inc (TAYD) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Taylor Devices Inc (TAYD) is a specialty industrial machinery company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported TAYD revenue for 2026-05-31 was $41.6M. Net income was $8.6M. Revenue was down 10.0% from 2025-05-31 to 2026-05-31. TAYD currently screens at market cap $170.7M and trailing P/E 16.8.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
TAYD currently screens at market cap $170.7M and trailing P/E 16.8. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the TAYD and UTHR stock pages for the full models.
Not investment advice.